Welcome to LookChem.com Sign In|Join Free
  • or
2-triisopropylsilyl oxazole is a heterocyclic chemical compound with the molecular formula C13H23NOSi. It features a five-membered oxazole ring that includes oxygen and nitrogen atoms, with a "2-triisopropylsilyl" group attached, which enhances the molecule's stability and protects its reactive sites. 2-triisopropylsilyl oxazole is recognized for its versatility and value in organic chemistry, particularly as a building block in the synthesis of pharmaceuticals and agrochemicals. Additionally, it has been investigated for its potential antifungal and antibacterial properties.

433332-27-5

Post Buying Request

433332-27-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

433332-27-5 Usage

Uses

Used in Organic Synthesis:
2-triisopropylsilyl oxazole serves as a crucial building block in organic synthesis, particularly for the preparation of pharmaceuticals and agrochemicals. Its unique structure and the presence of the "2-triisopropylsilyl" group contribute to the creation of complex organic molecules with specific therapeutic or pesticidal properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-triisopropylsilyl oxazole is utilized as a key intermediate in the synthesis of various drug molecules. Its stability and reactivity make it suitable for developing new medications with improved efficacy and reduced side effects.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 2-triisopropylsilyl oxazole is employed as a precursor in the production of pesticides and other crop protection agents. Its incorporation into these compounds can enhance their effectiveness against pests and diseases while minimizing environmental impact.
Used in Antifungal and Antibacterial Applications:
2-triisopropylsilyl oxazole has been studied for its potential as an antifungal and antibacterial agent. Its ability to protect reactive sites and its structural features make it a promising candidate for the development of new antimicrobial agents to combat drug-resistant infections.

Check Digit Verification of cas no

The CAS Registry Mumber 433332-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,3,3 and 2 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 433332-27:
(8*4)+(7*3)+(6*3)+(5*3)+(4*3)+(3*2)+(2*2)+(1*7)=115
115 % 10 = 5
So 433332-27-5 is a valid CAS Registry Number.

433332-27-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Triisopropylsilyloxazole

1.2 Other means of identification

Product number -
Other names 1,3-oxazol-2-yl-tri(propan-2-yl)silane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:433332-27-5 SDS

433332-27-5Relevant academic research and scientific papers

Antibacterial Mimics of Natural Products by Side-Chain Functionalization of Bicyclic Tetramic Acids

Josa-Culleré, Laia,Pretsch, Alexander,Pretsch, Dagmar,Moloney, Mark G.

, p. 10303 - 10317 (2018)

Tetramic acids with unsaturated acyl chains are widely found in natural products possessing a range of biological activities, and bicyclic tetramates represent a suitable scaffold to prepare simple mimics of such complex molecules. An efficient route to functionalize the C(6)-acyl group of a bicyclic tetramate was developed and utilized to prepare a small chemical library with a range of saturated and unsaturated side-chains. The analogues with lipophilic residues possessed highly potent antibacterial activity, which was selective for Gram-positive bacteria, and the best compound was 37-fold more potent than the cephalosporin C control and with an appropriate therapeutic window.

TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS

-

Page/Page column 136, (2021/04/23)

Disclosed are a series of compounds or their tautomers having a general structure represented by Formula la or lb and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising said compounds or tautomers or pharmaceutically acceptable salts thereof. Further disclosure relates to a method of treating a disease or condition associated with iron dysregulation or dysfunctional iron homeostasis, comprising administering to a subject in need thereof a therapeutically effective amount of Formula la or lb compounds or tautomers or pharmaceutically acceptable salts thereof.

ACC inhibitor and application thereof

-

Paragraph 0250-0252, (2021/05/12)

The invention provides a compound suitable for being used as an acetyl CoA carboxylase (ACC) inhibitor, in particular a thienopyridine derivative, and application of the compound in preparation of medicines for treating metabolic diseases, cancers or other proliferative diseases.

4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS

-

Paragraph 00221; 00232, (2021/06/26)

4-phenyl-N-(phenyl)thiazol-2-amine and 4-(pyridin-3-yl)-N-( phenyl) thiazol-2-amine derivatives and the corresponding thiadiazole, thiophene, oxazole, oxadiazole, imidazole and triazole derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders.

COMPOSITIONS FOR THE TREATMENT OF BRAIN TUMORS

-

Page/Page column 48, (2020/05/19)

The instant invention describes pharmaceutical compositions and dosing regimens comprising radiation therapy and seviteronel with or without dexamethasone, and methods of treating diseases, disorders or symptoms thereof.

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

-

Paragraph 1220, (2020/10/09)

The invention relates to modulators of Embryonic Ectoderm Development (EED) and/or Polycomb Repressive Complex 2 (PRC2) useful in the treatment of disorders and diseases associated with EEC and PRC2, being macrocyclic azolopyridine derivatives and compositions thereof of Formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, enantiomer, isomer, or tautomer thereof, wherein X1, X2, X3, A1, A2, Y, R1, R2, R3, and R4 are as described herein.

Preparation method of thienopyrimidinedione compound

-

Paragraph 0140-0142, (2020/02/20)

The invention provides a preparation method of a compound shown as a general formula c, wherein the definition of substituent is as defined in the specification. Please see the specification for the formula.

Widely Exploited, Yet Unreported: Regiocontrolled Synthesis and the Suzuki–Miyaura Reactions of Bromooxazole Building Blocks

Solomin, Vitalii V.,Radchenko, Dmytro S.,Slobodyanyuk, Evgeniy Y.,Geraschenko, Oleksandr V.,Vashchenko, Bohdan V.,Grygorenko, Oleksandr O.

, p. 2884 - 2898 (2019/03/07)

An approach to synthesis of 2-, 4-, and 5-bromooxazoles is described. The method was optimized, and its scope was extended to all three isomeric parents, as well as various alkyl- and aryl-substituted bromooxazoles. It was found that direct regiocontrolled lithiation followed by reaction with electrophilic bromine source was common for all substrates and led exclusively to the target substituted 2-, 4- and 5-bromooxazoles on multigram scale. The utility of the multipurpose building blocks obtained in this work was demonstrated in the Suzuki–Miyaura cross-coupling reaction under parallel synthesis conditions.

COMPOSITIONS FOR THE TREATMENT OF BRAIN TUMORS

-

Page/Page column 45-46, (2019/10/15)

The instant invention describes pharmaceutical compositions and dosing regimens comprising seviteronel and/or dexamethasone, and methods of treating diseases, disorders symptoms thereof.

Asymmetric Total Synthesis of (-)-(3 R)-Inthomycin C

Balcells, Sandra,Haughey, Maxwell B.,Walker, Johannes C. L.,Josa-Culleré, Laia,Towers, Christopher,Donohoe, Timothy J.

supporting information, p. 3583 - 3586 (2018/06/26)

A short (10 step) and efficient (15% overall yield) synthesis of the natural product (-)-(3R)-inthomycin C is reported. The key steps comprise three C-C bond-forming reactions: (i) a vinylogous Mukaiyama aldol, (ii) an olefin cross-metathesis reaction, and (iii) an asymmetric Mukaiyama-Kiyooka aldol. This route is notable for its brevity and has the advantage of lacking stoichiometric tin-promoted cross-coupling reactions present in previous approaches. Initial investigations on the biological activity of (-)-(3R)-inthomycin C and structural analogues on human cancer cell lines are also described for the first time.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 433332-27-5